CINECA IRIS Institutional Research Information System

LATROFA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.057
NA - Nord America 12.268
AS - Asia 4.742
SA - Sud America 955
AF - Africa 276
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 35.311
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.635
US - Stati Uniti d'America 9.685
CA - Canada 2.498
FI - Finlandia 1.998
SG - Singapore 1.463
CN - Cina 1.214
HK - Hong Kong 835
BR - Brasile 754
SE - Svezia 704
NL - Olanda 503
DE - Germania 483
VN - Vietnam 483
FR - Francia 352
BG - Bulgaria 269
GB - Regno Unito 255
AT - Austria 185
TR - Turchia 167
UA - Ucraina 151
RU - Federazione Russa 140
IN - India 121
JP - Giappone 99
CI - Costa d'Avorio 94
CH - Svizzera 63
AR - Argentina 60
SN - Senegal 59
PL - Polonia 54
KR - Corea 50
MX - Messico 48
ES - Italia 44
IQ - Iraq 43
BD - Bangladesh 40
ZA - Sudafrica 40
BE - Belgio 31
PY - Paraguay 30
EC - Ecuador 28
RO - Romania 27
ID - Indonesia 25
PK - Pakistan 24
LV - Lettonia 22
SA - Arabia Saudita 21
CO - Colombia 20
IE - Irlanda 20
VE - Venezuela 20
GR - Grecia 17
JO - Giordania 17
UZ - Uzbekistan 17
MA - Marocco 16
CL - Cile 15
EG - Egitto 15
DK - Danimarca 14
CZ - Repubblica Ceca 12
PE - Perù 12
PH - Filippine 12
IL - Israele 11
KZ - Kazakistan 11
ZM - Zambia 11
EE - Estonia 10
MY - Malesia 10
SM - San Marino 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
TH - Thailandia 9
AL - Albania 8
AZ - Azerbaigian 8
HU - Ungheria 8
JM - Giamaica 8
TW - Taiwan 8
AU - Australia 7
CR - Costa Rica 7
HR - Croazia 7
IR - Iran 7
TN - Tunisia 7
ET - Etiopia 6
NP - Nepal 6
PT - Portogallo 6
RS - Serbia 6
DZ - Algeria 5
LT - Lituania 5
MT - Malta 5
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
NG - Nigeria 4
OM - Oman 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LY - Libia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
EU - Europa 2
KG - Kirghizistan 2
LU - Lussemburgo 2
Totale 35.277
Salva come PNG Salva come JPEG
Città #
Montreal 2.330
Helsinki 1.897
Ashburn 1.028
Milan 933
Hong Kong 825
Dallas 815
Fairfield 767
Singapore 752
Woodbridge 746
Rome 678
Ann Arbor 582
San Jose 560
Santa Clara 546
Houston 501
Chandler 442
Seattle 328
Beijing 293
Florence 289
Naples 276
Sofia 262
Shanghai 258
Wilmington 256
New York 253
Cambridge 239
Serra 207
Bologna 164
Vienna 157
Ho Chi Minh City 152
Los Angeles 150
Boardman 148
Bari 140
Pisa 137
Princeton 121
Ottawa 119
Palermo 119
Turin 113
Lawrence 106
Munich 104
Hanoi 103
Lauterbourg 103
Medford 95
Abidjan 94
Catania 92
Brescia 81
Tokyo 80
Genoa 79
Hefei 78
Council Bluffs 74
London 67
Nanjing 67
Izmir 66
São Paulo 64
Des Moines 62
Dakar 59
Lucca 58
Padova 57
Dong Ket 56
Bremen 53
Redondo Beach 53
Vicopisano 53
Livorno 51
Cagliari 49
Frankfurt am Main 49
Buffalo 48
Verona 48
Seoul 47
Dearborn 44
Istanbul 43
San Diego 43
Orem 42
Jacksonville 37
Modena 37
Turku 37
Paris 36
Pescara 36
Redwood City 36
Bergamo 35
Marseille 34
Lancaster 32
Ogden 31
Guangzhou 29
Messina 29
Perugia 28
Napoli 27
Rio de Janeiro 27
Boulder 26
Nanchang 26
Chicago 25
Reggio Emilia 24
Monza 23
Venice 23
Ancona 22
Brooklyn 22
Brussels 22
Caserta 22
Columbus 22
Düsseldorf 22
Rende 22
Salerno 22
Toronto 22
Totale 20.687
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 12.597
Ipotiroidismo subclinico 3.557
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 295
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 243
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 239
Le malattie autoimmuni della tiroide 234
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 222
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 219
Diagnosi differenziale dell’oftalmopatia basedowiana 218
Effects Of Long-term Tamoxifen Therapy On The Course Of Chronic Autoimmune Thyroiditis 218
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 213
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 211
Subacute thyroiditis after Sars-COV-2 infection 209
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 204
Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? insights from a case series 202
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 201
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 200
Causes and laboratory investigations of thyrotoxicosis 200
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 198
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 197
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 196
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 194
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 193
Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin 193
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 190
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 188
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 187
Thyroglobulin Autoantibodies arise before Thyroperoxidase Autoantibodies in Juvenile Autoimmune Thyroiditis 187
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 186
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 184
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 183
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum‑negative thyroiditis requires a lower substitution dose of l‑thyroxine to correct hypothyroidism 183
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 182
Thyroid imaging in the management of anti-PD1/PD-L1 induced thyrotoxicosis 182
Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease 182
Circulating thyroglobulin transcytosed by thyroid cells is complexed with secretory components of its endocytic receptor megalin 181
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 181
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 180
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 178
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 177
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 177
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 177
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 177
Serum antibodies against megalin (gp330) in patients with autoimmune thyroiditis 176
Pathways to democratized healthcare: Envisioning human-centered AI-as-a-service for customized diagnosis and rehabilitation 175
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 175
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology 175
Effect of thyroglobulin autoantibodies on the clearance of serum thyroglobulin in humans 175
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 173
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 171
Pathogenetic and clinical aspects of autoimmune thyroiditis 170
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. 167
Human monoclonal thyroglobulin autoantibodies: epitopes and immunoglobulin genes. 167
IgM thyroglobulin autoantibodies are detectable in serum of patients with subacute thyroiditis 164
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 163
Subacute Thyroiditis during the SARS-CoV-2 Pandemic 158
Thyroid volume and severity of graves' orbitopathy 157
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 156
Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy 156
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib 155
Activating Antibodies to the Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism 155
Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway 154
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 153
The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors 151
COVID-induced thyroid autoimmunity 149
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 148
Evaluation of the Level of Thyroglobulin Autoantibodies Interfering with Thyroglobulin Measurement in Patients with Differentiated Thyroid Carcinoma 147
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction 145
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. 144
Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? 144
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 142
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade 137
The detection of serum IgMs to thyroglobulin in subacute thyroiditis suggests a protective role of IgMs in thyroid autoimmunity 137
Diffuse and Nodular Goiter 135
The detection of serum IgM to thyroglobulin in subacute thyroiditis suggests a protective role of IgM in thyroid autoimmunity 135
In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' orbitopathy 134
Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review 134
Diagnosi di laboratorio 132
Manifestaciones no oftalmológicas de la enfermedad de Graves 129
The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. 126
Un caso di MEN2B con anomalie scheletriche multiple 125
Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus 125
Thyroglobulin Autoantibodies Switch to IgG1 and IgG3 Subclasses after 131I Treatment for Graves' Hyperthyroidism: Autoantibodies Subclasses Are Related to the Activity of Autoimmune Thyroid Disease 123
Iodine, thyroid autoimmunity and cancer 123
null 121
Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. 121
Late-onset dyshormonogenic goitrous hypothyroidism due to a homozygous mutation of the SLC26A7 gene: a case report 121
null 120
Evidence that the thyrotropin receptor protease is membrane-associated and is not within lipid rafts 118
Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. 118
Frequency of the GPR7 Tyr135Phe allelic variant in lean and obese subjects. 115
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis 115
Over hypothyroidism in a woman undergoing controlled ovarian hyperstimulation. 114
Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1 111
Gozzo 110
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. 109
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 109
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 107
Altre terapie dell’oftalmopatia basedowiana 106
null 100
Totale 32.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 0 0 207
2021/20221.926 61 103 61 152 297 239 83 97 194 154 108 377
2022/20233.354 250 306 246 219 250 269 146 261 506 192 425 284
2023/20246.548 364 317 315 311 383 462 377 354 204 2.651 399 411
2024/20257.083 390 344 368 525 615 635 536 519 768 709 637 1.037
2025/20269.293 535 806 900 1.152 654 533 854 389 2.284 642 381 163
Totale 35.678